amantadine has been researched along with cyclopentane in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coulter, AW; Lombardini, JB; Sufrin, JR; Talalay, P | 1 |
| Kerr, ID; Sansom, MS | 1 |
| Escobar, MR; Fourie, J; Sitar, DS | 1 |
| Barr, IG; Brown, L; Hurt, AC; Komadina, N; Selleck, P; Shaw, R | 1 |
| Ishii, H; Kadota, J; Tokimatsu, I; Yoshioka, D | 1 |
| Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ | 1 |
| Sato, R | 1 |
| Ali, Z; Dapat, C; Dapat, IC; Dbaibo, G; Ghanem, S; Kayali, G; Kondo, H; Lteif, M; Saito, K; Saito, R; Suzuki, H; Zaraket, H | 1 |
| Ariza-Heredia, EJ; Chemaly, RF; Shahani, L | 1 |
4 review(s) available for amantadine and cyclopentane
| Article | Year |
|---|---|
[Current anti-influenza virus chemotherapy].
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Drug Utilization; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Infusions, Intravenous; Japan; Oseltamivir; Pandemics; Zanamivir | 2010 |
[Research progress of anti-influenza virus agents].
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir | 2010 |
[Drug resistance of influenza viruses].
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Viral Matrix Proteins; Zanamivir | 2012 |
Antiviral therapy for respiratory viral infections in immunocompromised patients.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Coronavirus Infections; Cyclopentanes; Guanidines; Humans; Immunocompromised Host; Influenza, Human; Oseltamivir; Palivizumab; Paramyxoviridae Infections; Picornaviridae Infections; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Zanamivir | 2017 |
5 other study(ies) available for amantadine and cyclopentane
| Article | Year |
|---|---|
Structural and conformational analogues of L-methionine as inhibitors of the enzymatic synthesis of S-adenosyl-l-methionine. 3. Carbocyclic and heterocyclic amino acids.
Topics: Adenosine Triphosphate; Amantadine; Amino Acids; Animals; Bridged-Ring Compounds; Camphanes; Carboxylic Acids; Crystallography; Cyclopentanes; Heterocyclic Compounds; Hydrolysis; Indenes; Isomerism; Methionine; Molecular Conformation; Nitro Compounds; Pyrrolidines; Rats; S-Adenosylmethionine; Structure-Activity Relationship; Sulfhydryl Compounds; Transferases; X-Ray Diffraction | 1974 |
Influenza virus M2 protein: a molecular modelling study of the ion channel.
Topics: Amantadine; Computer Simulation; Cyclopentanes; Influenza A virus; Ion Channels; Models, Molecular; Protein Structure, Secondary; Protein Structure, Tertiary; Protons; Receptors, Nicotinic; Sodium; Viral Matrix Proteins | 1993 |
NMDA receptor antagonists to characterize rat renal organic cation transporter function.
Topics: Amantadine; Animals; Cyclopentanes; Drug Interactions; Energy Metabolism; Excitatory Amino Acid Antagonists; In Vitro Techniques; Kidney; Kidney Tubules; Kinetics; Male; Memantine; Organic Cation Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2002 |
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Topics: Acids, Carbocyclic; Amantadine; Animals; Antiviral Agents; Base Sequence; Birds; Cyclopentanes; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Zanamivir | 2007 |
Characterization of human Influenza Viruses in Lebanon during 2010-2011 and 2011-2012 post-pandemic seasons.
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Lebanon; Microbial Sensitivity Tests; Mutation; Neuraminidase; Oseltamivir; Pandemics; Phylogeny; Pyrans; Sialic Acids; Zanamivir | 2014 |